0.32
0.32 (-0.65%)
As of Feb 12, 2024
Invivo Therapeutics Holdings Corp. [NVIV]
Source:
Company Overview
Invivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries, or SCIs. Our mission is to redefine the life of the SCI patient.
| Country | United States |
| Headquarters | cambridge, massachusetts |
| Phone Number | 617-863-5524 |
| Industry | manufacturing |
| CEO | Richard Toselli |
| Website | www.invivotherapeutics.com |